Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Prolonged international normalized ratio during the first year of warfarin treatment.

Bergman M, Dicker D, Blumberger N, Brener ZZ, Ori Y, Salman H.

Am J Med Sci. 2014 Jul;348(1):71-4. doi: 10.1097/MAJ.0000000000000209.

PMID:
24949726
2.

A study of elderly adults taking warfarin admitted with prolonged international normalized ratio: a community hospital's experience.

Bergman M, Ori Y, Blumberger N, Brener ZZ, Salman H.

J Am Geriatr Soc. 2012 Sep;60(9):1713-7. doi: 10.1111/j.1532-5415.2012.04103.x. Epub 2012 Aug 6.

PMID:
22880717
3.
4.

Admission international normalized ratio levels, early treatment strategies, and major bleeding risk among non-ST-segment-elevation myocardial infarction patients on home warfarin therapy: insights from the National Cardiovascular Data Registry.

Subherwal S, Peterson ED, Chen AY, Roe MT, Washam JB, Gage BF, Bach RG, Bhatt DL, Wiviott SD, Lopes RD, Alexander KP, Wang TY.

Circulation. 2012 Mar 20;125(11):1414-23. doi: 10.1161/CIRCULATIONAHA.111.059188. Epub 2012 Feb 8.

5.

Failure to correct International Normalized Ratio and mortality among patients with warfarin-related major bleeding: an analysis of electronic health records.

Menzin J, Hoesche J, Friedman M, Nichols C, Bergman GE, Crowther M, Garcia D, Jones C.

J Thromb Haemost. 2012 Apr;10(4):596-605. doi: 10.1111/j.1538-7836.2012.04636.x.

6.

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE.

Arch Intern Med. 2000 Jun 12;160(11):1612-7.

PMID:
10847254
8.
9.

Higher baseline international normalized ratio value correlates with higher mortality in intracerebral hemorrhage during warfarin use.

Curtze S, Strbian D, Meretoja A, Putaala J, Eriksson H, Haapaniemi E, Mustanoja S, Sairanen T, Satopää J, Silvennoinen H, Niemelä M, Kaste M, Tatlisumak T.

Eur J Neurol. 2014 Apr;21(4):616-22. doi: 10.1111/ene.12352. Epub 2014 Jan 21.

PMID:
24447727
10.

Preprocedural therapeutic international normalized ratio influence on bleeding complications in atrial fibrillation ablation with continued anticoagulation with warfarin.

Hayashi T, Kumagai K, Naito S, Goto K, Kaseno K, Ohshima S, Hachiya H, Hirao K, Isobe M.

Circ J. 2013;77(2):338-44. Epub 2012 Oct 20.

11.

Warfarin-antibiotic interactions in older adults of an outpatient anticoagulation clinic.

Ghaswalla PK, Harpe SE, Tassone D, Slattum PW.

Am J Geriatr Pharmacother. 2012 Dec;10(6):352-60. doi: 10.1016/j.amjopharm.2012.09.006. Epub 2012 Oct 22.

PMID:
23089199
12.

Intensity of anticoagulation with warfarin and risk of adverse events in patients presenting to the emergency department.

Anthony CJ, Karim S, Ackroyd-Stolarz S, Fry A, Murphy NG, Christie R, Zed PJ.

Ann Pharmacother. 2011 Jul;45(7-8):881-7. doi: 10.1345/aph.1P670. Epub 2011 Jul 12.

PMID:
21750309
13.

Influence of kidney function on risk of supratherapeutic international normalized ratio-related hemorrhage in warfarin users: a prospective cohort study.

Limdi NA, Nolin TD, Booth SL, Centi A, Marques MB, Crowley MR, Allon M, Beasley TM.

Am J Kidney Dis. 2015 May;65(5):701-9. doi: 10.1053/j.ajkd.2014.11.004. Epub 2014 Nov 25.

14.

Hemorrhagic events lead to an increase in international normalized ratio in patients on warfarin.

Perona S, Ford M, Rindone J.

J Pharm Pract. 2011 Oct;24(5):494-7. doi: 10.1177/0897190011418511.

PMID:
22156711
15.

Oral vitamin K versus placebo to correct excessive anticoagulation in patients receiving warfarin: a randomized trial.

Crowther MA, Ageno W, Garcia D, Wang L, Witt DM, Clark NP, Blostein MD, Kahn SR, Vesely SK, Schulman S, Kovacs MJ, Rodger MA, Wells P, Anderson D, Ginsberg J, Selby R, Siragusa S, Silingardi M, Dowd MB, Kearon C.

Ann Intern Med. 2009 Mar 3;150(5):293-300.

PMID:
19258557
16.

Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.

Takarada K, Sato M, Goto M, Saito A, Ikeda Y, Fujita S, Fuse K, Takahashi M, Oguro T, Matsushita H, Kitazawa H, Okabe M, Abe H, Toba K, Yamashina A, Aizawa Y.

J Cardiol. 2014 Aug;64(2):127-32. doi: 10.1016/j.jjcc.2013.11.015. Epub 2014 Jan 17.

17.

Incidence of thromboembolic complications in patients with atrial fibrillation or mechanical heart valves with a subtherapeutic international normalized ratio: a prospective multicenter cohort study.

Dentali F, Pignatelli P, Malato A, Poli D, Di Minno MN, Di Gennaro L, Rancan E, Pastori D, Grifoni E, Squizzato A, Siragusa S, Di Minno G, Ageno W.

Am J Hematol. 2012 Apr;87(4):384-7. doi: 10.1002/ajh.23119. Epub 2012 Feb 24. Erratum in: Am J Hematol. 2012 Jul;87(7):748. Grifoni, Elena [corrected to Grifoni, Elisa].

18.

Evaluation of the safety and efficacy of warfarin in Taiwanese patients.

Kuo LN, Liou JP, Chen HY, Chiang YC, Wu MT.

Int J Clin Pharmacol Ther. 2013 Feb;51(2):106-13.

PMID:
23351596
19.

Evaluation of warfarin management with international normalized ratio self-testing and online remote monitoring and management plus low-dose vitamin k with genomic considerations: a pilot study.

Bussey HI, Bussey M, Bussey-Smith KL, Frei CR.

Pharmacotherapy. 2013 Nov;33(11):1136-46. doi: 10.1002/phar.1343. Epub 2013 Aug 22.

PMID:
24038412
20.

Target international normalized ratio values for preventing thromboembolic and hemorrhagic events in Japanese patients with non-valvular atrial fibrillation: results of the J-RHYTHM Registry.

Inoue H, Okumura K, Atarashi H, Yamashita T, Origasa H, Kumagai N, Sakurai M, Kawamura Y, Kubota I, Matsumoto K, Kaneko Y, Ogawa S, Aizawa Y, Chinushi M, Kodama I, Watanabe E, Koretsune Y, Okuyama Y, Shimizu A, Igawa O, Bando S, Fukatani M, Saikawa T, Chishaki A; J-RHYTHM Registry Investigators.

Circ J. 2013;77(9):2264-70. Epub 2013 May 25.

Supplemental Content

Support Center